Orca Bio

Associate Director, Site Profiling and Institutional Insights

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

The Associate Director of Site Profiling & Institutional Insights should possess a Bachelor’s degree in a relevant field, such as Business, Marketing, Healthcare Administration, or a related discipline, and have at least 7 years of experience in market access, commercial operations, or a similar role within the biotechnology or pharmaceutical industry. Strong analytical skills, including data interpretation and segmentation, are essential, along with experience in developing and implementing strategic plans. Experience with CRM systems and proficiency in Microsoft Office Suite are also required.

Responsibilities

This role involves developing and managing a national profiling program to assess treatment center readiness, create tailored activation plans, and provide actionable insights to field teams. The Associate Director will lead data collection through surveys and interviews, segment treatment centers, and collaborate with Market Enablement to translate profiles into onboarding playbooks. They will also integrate field strategy with sales and marketing, deliver comprehensive site intelligence, contribute to forecasting, and monitor institutional adoption curves, ensuring ongoing operational readiness and supporting the successful launch of ORCA-T.

Skills

Site Profiling
Institutional Insights
Data Collection
Market Enablement
Technical Operations
Sales
Commercial Operations
Medical Affairs
Forecasting
Qualitative and Quantitative Analysis
CRM

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI